CANERTINIB Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A quinazoline compound having a 3-chloro-4-fluoroanilino group at the 4-position, a propenamido group at the 6-position, and a 3-morpholinopropoxy group at the 7-position. (Chemical Entities of Biological Interest Ontology, CHEBI_61399)
External Link https://dgidb.org/results?searchType=drug&searchTerms=CANERTINIB
Similar Terms
Downloads & Tools

Genes

5 interacting proteins for the CANERTINIB drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
BMX BMX non-receptor tyrosine kinase 1.41152
ERBB2 erb-b2 receptor tyrosine kinase 2 0.274259
EGFR epidermal growth factor receptor 0.254656
MTOR mechanistic target of rapamycin (serine/threonine kinase) 0.0598102
YES1 YES proto-oncogene 1, Src family tyrosine kinase 0.0497014